Potential Infectious Etiologies of Atherosclerosis: a Multifactorial Perspective

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2001 Dec 19

PMID 11747688

Citations 23

Authors

S OConnor

C Taylor

L A Campbell

S Epstein

P Libby

Affiliations

Soon will be listed here.

Abstract

Coronary heart disease (CHD) contributes substantially to illness and death worldwide. Experimental studies demonstrate that infection can stimulate atherogenic processes. This review presents a spectrum of data regarding the link between CHD and infection. In addition, the need for improved diagnostic tools, the significance of multiple pathogens, and potential intervention strategies are discussed.

Citing Articles

CAIP-Induced ROS Production Contributes to Sustaining Atherosclerotic Process Associated with Infection through Macrophages and Endothelial Cells Activation.

Paolini E, Cozzi S, Codolo G Int J Mol Sci. 2024; 25(17).

PMID: 39273324 PMC: 11394679. DOI: 10.3390/ijms25179377.

Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.

Gaspar Z, Szabo B, Cegledi A, Lakatos B Geroscience. 2024; 47(1):167-187.

PMID: 39207648 PMC: 11872864. DOI: 10.1007/s11357-024-01323-9.

Mathematical model of aging in COVID-19.

Jovanikic O, Stevanovic G, dordevic B, Jovanovic M, Lepic M J Med Biochem. 2023; 42(3):383-391.

PMID: 37814624 PMC: 10560502. DOI: 10.5937/jomb0-39602.

The oral microbiota in patients undergoing coronary artery bypass graft surgery.

Menon T, Kalyanaraman S Indian J Thorac Cardiovasc Surg. 2023; 39(5):501-504.

PMID: 37609623 PMC: 10441894. DOI: 10.1007/s12055-023-01529-0.

Prevalence of fimbriae A genotypes II and IV in patients with chronic periodontitis and atherosclerosis.

Talebi Ardakani M, Esmaeil Nejad A, Kazemi B, Forouzan Nia S, Poormohamadi M, Moaven H J Adv Periodontol Implant Dent. 2022; 10(2):50-57.

PMID: 35919895 PMC: 9327568. DOI: 10.15171/japid.2018.009.

References

Adler S, Hur J, Wang J, Vetrovec G . Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 1998; 177(1):209-12. DOI: 10.1086/517355. View

Thomas M, Wong Y, Thomas D, Ajaz M, Tsang V, Gallagher P . Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation. 1999; 99(21):2733-6. DOI: 10.1161/01.cir.99.21.2733. View

Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P . Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997; 65(11):4832-5. PMC: 175693. DOI: 10.1128/iai.65.11.4832-4835.1997. View

Zhu J, Nieto F, Horne B, Anderson J, Muhlestein J, Epstein S . Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001; 103(1):45-51. DOI: 10.1161/01.cir.103.1.45. View

Meydani M, Lipman R, Han S, Wu D, Beharka A, Martin K . The effect of long-term dietary supplementation with antioxidants. Ann N Y Acad Sci. 1999; 854:352-60. DOI: 10.1111/j.1749-6632.1998.tb09915.x. View

Arason V, Kristinsson K, Sigurdsson J, Stefansdottir G, Molstad S, Gudmundsson S . Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ. 1996; 313(7054):387-91. PMC: 2351797. DOI: 10.1136/bmj.313.7054.387. View

Campbell L, Kuo C, GRAYSTON J . Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 1998; 4(4):571-9. PMC: 2640250. DOI: 10.3201/eid0404.980407. View

Zhou Y, Shou M, Guetta E, Guzman R, Unger E, Yu Z . Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999; 100(14):1569-75. DOI: 10.1161/01.cir.100.14.1569. View

Davidson M, Kuo C, Middaugh J, Campbell L, Wang S, Newman 3rd W . Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998; 98(7):628-33. DOI: 10.1161/01.cir.98.7.628. View

10.

Smith K, Parsonnet J . Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1997; 336(8):587; author reply 588. DOI: 10.1056/NEJM199702203360816. View

11.

Danesh J, Collins R, Peto R . Chronic infections and coronary heart disease: is there a link?. Lancet. 1997; 350(9075):430-6. DOI: 10.1016/S0140-6736(97)03079-1. View

12.

Nieto F, Folsom A, Sorlie P, GRAYSTON J, Wang S, Chambless L . Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999; 150(2):149-56. DOI: 10.1093/oxfordjournals.aje.a009974. View

13.

Moazed T, Campbell L, Rosenfeld M, GRAYSTON J, Kuo C . Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 1999; 180(1):238-41. DOI: 10.1086/314855. View

14.

Joshipura K, Douglass C, Willett W . Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol. 1998; 3(1):175-83. DOI: 10.1902/annals.1998.3.1.175. View

15.

Zhou Y, Leon M, Waclawiw M, Popma J, Yu Z, Finkel T . Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996; 335(9):624-30. DOI: 10.1056/NEJM199608293350903. View

16.

Anderson J, Muhlestein J, Carlquist J, Allen A, Trehan S, Nielson C . Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with.... Circulation. 1999; 99(12):1540-7. DOI: 10.1161/01.cir.99.12.1540. View

17.

West R . Commentary: adjustment for potential confounders may have been taken too far. BMJ. 2000; 321(7255):213. View

18.

Muhlestein J, Anderson J, Carlquist J, Salunkhe K, Horne B, Pearson R . Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation. 2000; 102(15):1755-60. DOI: 10.1161/01.cir.102.15.1755. View

19.

Kalayoglu M, Hoerneman B, LaVerda D, Morrison S, Morrison R, Byrne G . Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis. 1999; 180(3):780-90. DOI: 10.1086/314931. View

20.

Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P . Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 2000; 321(7255):208-13. PMC: 27437. DOI: 10.1136/bmj.321.7255.208. View